PBE ETF

$80.22
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 33 holdings— Unlock all holdings(as of Dec 31, 2025)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1ILMNIllumina, Inc.5.13%101,643$13.33M••••••••••••••••••••••
2UTHRUnited Therapeutics Corp5.03%26,829$13.07M••••••••••••••••••••••
3REGNRegeneron Pharmaceuticals, Inc.5.00%16,813$12.98M••••••••••••••••••••••
4BIIBBiogen Inc. Com4.91%72,406$12.74M••••••••••••••••••••••
5AMGNAmgen Inc.4.83%38,297$12.53M••••••••••••••••••••••
6GILDGilead Sciences Inc4.83%102,202$12.54M••••••••••••••••••••••
7INCYIncyte Corporation Ltd.4.58%120,509$11.90M••••••••••••••••••••••
8ALNYAlnylam Pharmace4.51%29,483$11.72M••••••••••••••••••••••
9FOLDAmicus Therapeutics Inc3.87%706,109$10.05M••••••••••••••••••••••
10DVAXDynavax Technologi Com New3.61%610,438$9.39M••••••••••••••••••••••
11BCRXBioCryst Pharmaceuticals Inc.3.07%1,022,462$7.98M••••••••••••••••••••••
12ACADAcadia Pharmaceuticals Inc Common Stock Usd 0.00013.00%292,193$7.80M••••••••••••••••••••••
13MNKDMannkind Corp.2.97%1,361,290$7.72M••••••••••••••••••••••
14BMRNBiomarin Pharmaceutical Inc.2.88%125,827$7.48M••••••••••••••••••••••
15EXELExelixis Inc2.79%165,287$7.24M••••••••••••••••••••••
16COLLCollegium Pharmaceutical Inc2.73%153,229$7.09M••••••••••••••••••••••
17IONSIonis Pharmaceuticals Inc2.71%88,937$7.04M••••••••••••••••••••••
18NBIXNeurocrine Bioscienc2.70%49,439$7.01M••••••••••••••••••••••
19PTGXProtagonist Therapeutics Inc2.68%79,637$6.96M••••••••••••••••••••••
20CPRXCarver Bancorp Inc.2.67%297,040$6.93M••••••••••••••••••••••
13+ more holdings available
See all 33 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

PBE ETF All Holdings

PBE holdings total 33 positions. The top 10 holdings account for 46.3% of the fund, led by Illumina, Inc. at 5.1%, United Therapeutics Corp at 5.0%, Regeneron Pharmaceuticals, Inc. at 5.0%.

PBE portfolio concentration is moderate, with the top 10 representing 46.3% of total assets. The largest sector exposure is Health Care at 94.7%.

PBE sector allocation provides a detailed breakdown. PBE overlap tool shows how holdings compare to other funds in your portfolio.

PBE ETF Holdings

33 of 33 holdings

  • 1

    Illumina, Inc.

    ILMNHealth Care
    5.13%
  • 2

    United Therapeutics Corp

    UTHRHealth Care
    5.03%
  • 3

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    5.00%
  • 4

    Biogen Inc. Com

    BIIBHealth Care
    4.91%
  • 5

    Amgen Inc.

    AMGNHealth Care
    4.83%
  • 6

    Gilead Sciences Inc

    GILDHealth Care
    4.83%
  • 7

    Incyte Corporation Ltd.

    INCYHealth Care
    4.58%
  • 8

    Alnylam Pharmace

    ALNYHealth Care
    4.51%
  • 9

    Amicus Therapeutics Inc

    FOLDHealth Care
    3.87%
  • 10

    Dynavax Technologi Com New

    DVAXHealth Care
    3.61%
  • 11

    BioCryst Pharmaceuticals Inc.

    BCRXHealth Care
    3.07%
  • 12

    Acadia Pharmaceuticals Inc Common Stock Usd 0.0001

    ACADHealth Care
    3.00%
  • 13

    Mannkind Corp.

    MNKDHealth Care
    2.97%
  • 14

    Biomarin Pharmaceutical Inc.

    BMRNHealth Care
    2.88%
  • 15

    Exelixis Inc

    EXELHealth Care
    2.79%
  • 16

    Collegium Pharmaceutical Inc

    COLLHealth Care
    2.73%
  • 17

    Ionis Pharmaceuticals Inc

    IONSHealth Care
    2.71%
  • 18

    Neurocrine Bioscienc

    NBIXHealth Care
    2.70%
  • 19

    Protagonist Therapeutics Inc

    PTGXHealth Care
    2.68%
  • 20

    Carver Bancorp Inc.

    CPRXHealth Care
    2.67%
  • 21

    Madrigal Pharmaceuticals Inc

    MDGLHealth Care
    2.66%
  • 22

    Repligen Corp

    RGENHealth Care
    2.63%
  • 23

    Rpi International Holdings Lp P/P

    RPD:DUFinancials
    2.61%
  • 24

    Ptc Therapeutics Inc

    PTCTHealth Care
    2.56%
  • 25

    Qiagen Nv

    QGEN:SGUnknown
    2.56%
  • 26

    Tg Therapeutics Inc Common Stock

    TGTXHealth Care
    2.50%
  • 27

    Bio Techne

    TECHHealth Care
    2.49%
  • 28

    Vericel Corp

    VCELHealth Care
    2.49%
  • 29

    Halozyme Therapeutics Inc

    HALOHealth Care
    2.45%
  • 30

    Veracyte, Inc.

    VCYTHealth Care
    2.42%
  • 31

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    0.11%
  • 32

    Undefined Holding

    Other
    0.00%
  • 33

    Cash & Equivalents

    Other
    0.00%